432 related articles for article (PubMed ID: 9264271)
1. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer.
Hsueh YM; Chiou HY; Huang YL; Wu WL; Huang CC; Yang MH; Lue LC; Chen GS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):589-96. PubMed ID: 9264271
[TBL] [Abstract][Full Text] [Related]
2. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
3. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
4. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.
Huang YK; Tseng CH; Huang YL; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):135-42. PubMed ID: 17173945
[TBL] [Abstract][Full Text] [Related]
5. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer.
Chung CJ; Hsueh YM; Bai CH; Huang YK; Huang YL; Yang MH; Chen CJ
Cancer Causes Control; 2009 Nov; 20(9):1653-61. PubMed ID: 19680750
[TBL] [Abstract][Full Text] [Related]
7. Arsenic methylation capacity and skin cancer.
Yu RC; Hsu KH; Chen CJ; Froines JR
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1259-62. PubMed ID: 11097236
[TBL] [Abstract][Full Text] [Related]
8. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
[TBL] [Abstract][Full Text] [Related]
9. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
10. Urinary arsenic species and CKD in a Taiwanese population: a case-control study.
Hsueh YM; Chung CJ; Shiue HS; Chen JB; Chiang SS; Yang MH; Tai CW; Su CT
Am J Kidney Dis; 2009 Nov; 54(5):859-70. PubMed ID: 19682779
[TBL] [Abstract][Full Text] [Related]
11. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis.
Wu MM; Chiou HY; Hsueh YM; Hong CT; Su CL; Chang SF; Huang WL; Wang HT; Wang YH; Hsieh YC; Chen CJ
Toxicol Appl Pharmacol; 2006 Oct; 216(1):168-75. PubMed ID: 16806340
[TBL] [Abstract][Full Text] [Related]
12. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM
Food Chem Toxicol; 2008 Mar; 46(3):929-38. PubMed ID: 18054417
[TBL] [Abstract][Full Text] [Related]
13. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
[TBL] [Abstract][Full Text] [Related]
14. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan.
Chiou HY; Hsueh YM; Liaw KF; Horng SF; Chiang MH; Pu YS; Lin JS; Huang CH; Chen CJ
Cancer Res; 1995 Mar; 55(6):1296-300. PubMed ID: 7882325
[TBL] [Abstract][Full Text] [Related]
15. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
[TBL] [Abstract][Full Text] [Related]
16. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015
[TBL] [Abstract][Full Text] [Related]
17. Hypertension incidence after tap-water implementation: a 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan.
Wang SL; Li WF; Chen CJ; Huang YL; Chen JW; Chang KH; Tsai LY; Chou KM
Sci Total Environ; 2011 Oct; 409(21):4528-35. PubMed ID: 21872294
[TBL] [Abstract][Full Text] [Related]
18. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan.
Hsueh YM; Huang YL; Huang CC; Wu WL; Chen HM; Yang MH; Lue LC; Chen CJ
J Toxicol Environ Health A; 1998 Jul; 54(6):431-44. PubMed ID: 9661909
[TBL] [Abstract][Full Text] [Related]
19. The relationship between obesity, insulin and arsenic methylation capability in Taiwan adolescents.
Su CT; Lin HC; Choy CS; Huang YK; Huang SR; Hsueh YM
Sci Total Environ; 2012 Jan; 414():152-8. PubMed ID: 22104380
[TBL] [Abstract][Full Text] [Related]
20. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
